Применение ингаляционной терапии таурактантом в подостром периоде covid-

HIGHLIGHTS

  • who: u041fu0440u0438u043cu0435u043du0435u043du0438u0435 u0438u043du0433u0430u043bu044fu0446u0438u043eu043du043du043eu0439 u0442u0435u0440u0430u043fu0438u0438 u0442u0430u0443u0440u0430u043au0442u0430u043du0442u043eu043c and collaborators from the Sechenov First Moscow State Medical University (Sechenov University)119991, Russia have published the Article: u041fu0440u0438u043cu0435u043du0435u043du0438u0435 u0438u043du0433u0430u043bu044fu0446u0438u043eu043du043du043eu0439 u0442u0435u0440u0430u043fu0438u0438 u0442u0430u0443u0440u0430u043au0442u0430u043du0442u043eu043c u0432 u043fu043eu0434u043eu0441u0442u0440u043eu043c u043fu0435u0440u0438u043eu0434u0435 COVID-, in the Journal: (JOURNAL) of June/08,/2022
  • what: The paper describes a clinical observation with the use of inhaled therapy with surfactant 150 mg/day for 7 days in a patient who underwent COVID-associated pneumonia with persistent ventilation disorders decreased exercise tolerance and characteristic changes identified due to the multispiral computed tomography examination.

SUMMARY

    В России число официально подтвержденных случаев COVID-­ 19 по состоянию на декабрь 2022 г. составляет 21 . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?